Atopic Dermatitis Drugs Market 2017 Trends, Growth and Forecast to 2021
ReportsWeb.com published “Atopic Dermatitis Drugs Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, July 27, 2017 ) Atopic dermatitis is a common, chronic, relapsing, inflammatory disease that primarily affects young children. Atopy refers to an inherited tendency to produce IgE antibodies, whereas, dermatitis means inflammation of the skin. Atopic dermatitis is associated with asthma, inhalant allergies (hay fever), and chronic dermatitis. In this condition, the skin becomes extremely itchy and inflamed, which causes redness, cracking, weeping, swelling, vesicle formation, crushing, and scaling. Atopic dermatitis is very common worldwide, and its prevalence rate is increasing. The data estimates suggest that nearly 60% of the patients develop symptoms in the first year of life, and 88%-92% develop symptoms before the age of five.
Publisher's analysts forecast the global atopic dermatitis drugs market to grow at a CAGR of 4.20% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-atopic-dermatitis-drugs-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global atopic dermatitis drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of atopic dermatitis drugs.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Atopic Dermatitis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- LEO Pharma
- Mylan
- Valeant
- Bayer HealthCare
- Encore Dermatology
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001608750/sample .
Market driver
- Growing prevalence of food allergies exacerbating atopic dermatitis
- For a full, detailed list, view our report
Market challenge
- Poor patient adherence due to inadequate information on drug usage
- For a full, detailed list, view our report
Market trend
- Increasing M&A leading to market consolidation
- For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001608750/buying .
Publisher's analysts forecast the global atopic dermatitis drugs market to grow at a CAGR of 4.20% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-atopic-dermatitis-drugs-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global atopic dermatitis drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of atopic dermatitis drugs.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Atopic Dermatitis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- LEO Pharma
- Mylan
- Valeant
- Bayer HealthCare
- Encore Dermatology
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001608750/sample .
Market driver
- Growing prevalence of food allergies exacerbating atopic dermatitis
- For a full, detailed list, view our report
Market challenge
- Poor patient adherence due to inadequate information on drug usage
- For a full, detailed list, view our report
Market trend
- Increasing M&A leading to market consolidation
- For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001608750/buying .
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results